Cobenfy

• 11/13/2024

  AbbVie’s Schizophrenia Drug Fails, Bristol Myers Squibb Gains Edge

• 11/4/2024

  Bristol Myers Squibb Smashes Q3 Earnings Expectations

• 9/28/2024

  **FDA Approves Groundbreaking Schizophrenia Treatment**